Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis [Phase 2]
Phase 2 trial update for LYC-30937-EC in moderate chronic plaque-type psoriasis completed with posted results in 2019.
-
CLINICAL_TRIALS research · 2019-04-01Clinical Trial Update: Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity [Phase 4]
Phase 4 trial evaluating tight control dose reductions of biologics in psoriasis patients with low disease activity.
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis [Phase 2]
Phase 2 clinical trial updating the efficacy and safety of acitretin plus pioglitazone in psoriasis.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants. [Phase 3]
A Phase 3 clinical trial update on secukinumab in psoriasis patients with inadequate response to TNF inhibitors completed in 2019 with resul…
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP) [Phase 3]
Phase 3 trial assessing secukinumab in Japanese patients with generalized pustular psoriasis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: A Study of Ixekizumab in Participants With Plaque Psoriasis [Phase 1]
Phase 1 clinical trial update for ixekizumab in plaque psoriasis with completed status and posted results.
-
EMA withdrawal · 2019-03-06EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH
The EMA withdrew Cyltezo (adalimumab) from Boehringer Ingelheim International GmbH, affecting multiple indications including hidradenitis su…
-
EMA withdrawal · 2019-03-05EMA Withdrawn: Solymbic (adalimumab) — Amgen Europe B.V.
Solymbic (adalimumab) has been withdrawn from the market by Amgen Europe B.V.
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating efficacy and safety of CP-690,550 (tofacitinib) in Asian subjects with moderate to severe psoriasis completed; resu…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test [Phase 1]
Pfizer completed a Phase I trial evaluating a novel ointment for psoriasis in a plaque test.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis [Phase 2]
A Phase 2 trial comparing HAT1 to calcipotriol in mild-to-moderate chronic plaque psoriasis has completed and reports on efficacy and safety…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: MSB11022 in Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial update for MSB11022 in moderate to severe chronic plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Potential Research Study Participant Registry
This update notes the completion of a University of California, Davis-sponsored clinical trial participant registry focused on several skin …
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene [Phase 2]
Phase 2 trial evaluating SNA-120 for pruritus and psoriasis in patients treated with calcipotriene, focusing on safety, tolerability, and ef…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]
Phase 3 trial evaluating two dose regimens of risankizumab subcutaneous in Japanese patients with generalized pustular psoriasis or erythrod…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
Phase 2 trial assessing risankizumab versus placebo in Japanese patients with moderate to severe chronic plaque psoriasis; results posted af…
-
CLINICAL_TRIALS research · 2019-02-04Clinical Trial Update: Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis [Phase 4]
Phase 4 trial evaluating Enstilar in combination with Enbrel or Humira for plaque psoriasis; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2019-01-30Clinical Trial Update: An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients [NA]
This clinical trial update describes an open-label pilot study evaluating narrowband UV-B phototherapy three times weekly for twelve weeks i…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients [Phase 2]
Phase 2 study of oral MP1032 in psoriasis patients has completed and results have been posted. The trial evaluated safety and efficacy in pl…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 [Phase 1]
Phase 1 single-dose study assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of AMG 827 in psoriasis completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: The Immunological Basis for Treatment Resistance to Anti-TNF Treatments [Phase 4]
Phase 4 trial investigating the immunological basis for treatment resistance to anti-TNF therapies in psoriasis; results completed.
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques [Phase 2]
A Phase 2 trial investigating subcutaneous hyaluronidase administration for psoriatic plaques has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-28Clinical Trial Update: Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers [Phase 3]
Phase 3 clinical trial update for secukinumab in psoriasis, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-12-26Clinical Trial Update: Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris [Phase 2]
Phase 2 trial evaluating efficacy of ustekinumab followed by abatacept for psoriasis vulgaris has completed with results posted.
-
FDA approval · 2018-12-26FDA Approved: CLOBETASOL PROPIONATE — Original Application (AvKARE)
FDA approved AvKARE's original ANDA for clobetasol propionate topical product (generic).